SCHEDULE 13G/A: ArrowMark Colorado Holdings Amends Axogen, Inc. Stake Disclosure to 3.59%

ArrowMark Colorado Holdings, LLC has filed an Amendment No. 9 to its Schedule 13G, disclosing a 3.59% beneficial ownership stake in Axogen, Inc. as of March 31, 2025.

Summary

• ArrowMark Colorado Holdings, LLC reported beneficial ownership of 1,591,103 shares of Axogen, Inc. Common Stock.
• This ownership represents 3.59% of the total class of Axogen, Inc. securities.
• The filing is an Amendment No. 9 to a previously filed Schedule 13G, indicating an update to their ownership position.
• ArrowMark Colorado Holdings, LLC, identified as an investment adviser, holds sole voting power and sole dispositive power over all 1,591,103 reported shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Axogen, Inc.

Sentiment

Score: 5

Explanation: This filing is a routine disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Axogen, Inc.'s future outlook.

Industry Context

This filing represents a routine disclosure by an investment adviser, ArrowMark Colorado Holdings, LLC, regarding its passive ownership stake in Axogen, Inc. Such disclosures are standard practice in the financial industry to provide transparency on significant shareholdings.

Stakeholder Impact

• Informs the market and other shareholders of ArrowMark Colorado Holdings, LLC's continued significant, but passive, ownership position in Axogen, Inc.

Key Dates

Keywords

Axogen Inc., ArrowMark Colorado Holdings LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing